3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Lung Neoplasms
10
Small Cell Lung Carcinoma
4
Esophageal Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Breast Neoplasms
3
Salivary Gland Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Nasopharyngeal Neoplasms
2
Mouth Neoplasms
2
Mesothelioma, Malignant
2
Liver Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Fallopian Tube Neoplasms
2
Congenital Abnormalities
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Waldenstrom Macroglobulinemia
1
Tobacco Use Disorder
1
Testicular Neoplasms
1
Teratoma, Testicular
1
Interventions
pembrolizumab
9
Nivolumab
4
Carboplatin
4
spartalizumab
2
durvalumab
2
Paclitaxel
2
Immunohistochemistry
2
Gemcitabine
2
Cisplatin
2
Bevacizumab
2
130-nm albumin-bound paclitaxel
2
tremelimumab
1
ribociclib
1
regorafenib
1
obinutuzumab
1
naptumomab estafenatox
1
liposomal doxorubicin
1
enzalutamide
1
atezolizumab
1
aflibercept
1
abiraterone
1
SGN-LIV1A
1
Ritonavir
1
Remote Patient Monitoring
1
Polymerase Chain Reaction
1
Oxaliplatin
1
NEO212
1
Mass Spectrometry
1
Lopinavir
1
Leucovorin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
Polymerase Chain Reaction
×
Thoracic
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled